NCT02154490 2023-06-01Lung-MAP: Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung CancerSWOG Cancer Research NetworkCompleted1,864 enrolled 12 charts
NCT01782690 2018-07-23An Observational Study of Erlotinib Plus Gemcitabine in Patients With Metastatic Pancreatic CancerHoffmann-La RocheCompleted338 enrolled 18 charts